TenX Keane Acquisition announced that it has raised $200,000 in a debt round of funding from new lender Citius Pharmaceuticals, Inc. on January 17, 2024. The company has issued Non Convertible Zero Coupon Promissory Note in the transaction. The note bears no interest and is repayable in full per the terms of the Merger Agreement.